Search

everythinglearnresearchcommunity

for

Search:↓

Early balding linked to higher heart disease risk.

Long-term finasteride use doesn't change bone density or metabolism.

Finasteride may negatively affect male fertility.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Bright light during the day doesn't change most human clock genes but may slightly increase Rev-erb-ß.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

Splitting one hair follicle into two can help regrow hair with a 50% to 70% success rate, useful when donor hair is limited.

Loss of the Y chromosome and UTY gene activity increases cancer risk in men.

Higher levels of heat shock protein 27 and lower levels of miR-1 can increase AR levels, leading to hair loss in men.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Ultrasound shows 80% of Hidradenitis Suppurativa patients have abnormal hair tracts that may worsen the condition.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Night shift work disrupts the body's natural clock genes.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Blocking Prostaglandin D₂ may help treat hair loss.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Alopecia areata may be linked to hearing problems, so patients should monitor their hearing.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.